This ADC product is composed of an anti-ITGB3 antibody (clone Tadocizumab) conjuagated via a RGD linker to MMAE-HAS (MF-T-RGD-MMAE-HAS). It has demonstrated a response in Solid malignancies treatment by a MOA (Mechanism of Action) of Depolymerize Microtubules.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For research use only. Not intended for any clinical use.